# Maintenance Chemotherapy After Neoadjuvant Chemoradiation Therapy for Distal Rectal Cancer

> **NCT01613469** · PHASE2 · TERMINATED · sponsor: **Marks, John, M.D.** · enrollment: 5 (actual)

## Conditions studied

- Rectal Neoplasms

## Interventions

- **DRUG:** 5FU/Leucovorin

## Key facts

- **NCT ID:** NCT01613469
- **Lead sponsor:** Marks, John, M.D.
- **Sponsor class:** INDIV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-08
- **Primary completion:** 2017-03-16
- **Final completion:** 2017-03-16
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Re-eval of patient population
- **Last updated:** 2018-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01613469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01613469, "Maintenance Chemotherapy After Neoadjuvant Chemoradiation Therapy for Distal Rectal Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01613469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*